{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-070910","form_type":"8-K","ticker":"CALC","cik":"0001534133","company_name":"CalciMedica, Inc.","filed_at":"2025-05-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.664379+00:00","generated_at":"2026-05-21T08:37:25.959647+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"CalciMedica Q1 2025 net loss $5.9M; cash $24.6M; KOURAGE trial data due end of 2025","bullets":["Net loss of $5.9M in Q1 2025 vs. net income of $0.1M in Q1 2024; R&D expenses rose to $4.2M.","Cash, cash equivalents and short-term investments of $24.6M; runway expected into mid-2026.","Phase 2 KOURAGE trial (AKI + respiratory failure) enrollment ongoing; data expected around end of 2025.","Post-hoc analysis from CARDEA showed 62.7% relative mortality reduction for Auxora vs. placebo in AKI subset.","End-of-Phase 2 meeting with FDA for AP/SIRS planned mid-2025; credit facility with Avenue Capital ($32.5M total)."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-070910","json":"https://secwatch.observer/filing/0000950170-25-070910.json","markdown":"https://secwatch.observer/filing/0000950170-25-070910.md","text":"https://secwatch.observer/filing/0000950170-25-070910.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534133/000095017025070910/0000950170-25-070910-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534133/000095017025070910/ck0001534133-20250514.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T08:37:25.959647+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}